AZN
Astrazeneca PLC
$164.50
-4.97 (-2.93%)
At close · Jul 14
Market Cap
$260.52B
Shares
1,550,876,987
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-14 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-05-29 | — | |
| 6-K | 2026-05-27 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-05-01 | — | |
| 6-K | 2026-05-01 | — | |
| 6-K | 2026-05-01 | — | |
| 6-K | 2026-04-29 | — | |
| 6-K | 2026-04-28 | — | |
| 6-K | 2026-04-27 | — | |
| 6-K | 2026-04-23 | — | |
| 6-K | 2026-04-21 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-09 | — | |
| 6-K | 2026-04-02 | — | |
| 6-K | 2026-04-01 | — | |
| 6-K | 2026-03-31 | — | |
| 6-K | 2026-03-27 | — | |
| 6-K | 2026-03-20 | — | |
| 6-K | 2026-03-16 | — | |
| 6-K | 2026-03-10 | — | |
| 6-K | 2026-03-10 | — | |
| 6-K | 2026-03-06 | — | |
| 6-K | 2026-03-06 | — | |
| 6-K | 2026-03-06 | — | |
| 6-K | 2026-03-02 | — | |
| 6-K | 2026-03-02 | — | |
| 6-K | 2026-02-26 | — | |
| 6-K | 2026-02-25 | — | |
| 20-F | 2026-02-24 | 2025-12-31 | |
| 6-K | 2026-02-24 | — | |
| 6-K | 2026-02-24 | — | |
| 6-K | 2026-02-24 | — | |
| 6-K | 2026-02-20 | — | |
| 6-K | 2026-02-10 | — | |
| 6-K | 2026-02-03 | — |
Showing 1–50 of 718 filings